HealthEquity (NASDAQ:HQY) Shares Down 6.8%

HealthEquity, Inc. (NASDAQ:HQY) fell 6.8% during mid-day trading on Friday . The stock traded as low as $61.93 and last traded at $62.00. 535,191 shares traded hands during mid-day trading, a decline of 18% from the average session volume of 652,802 shares. The stock had previously closed at $66.49.

Analyst Ratings Changes

Several research firms have recently issued reports on HQY. Royal Bank of Canada boosted their price target on shares of HealthEquity from $75.00 to $77.00 and gave the company an “outperform” rating in a research report on Wednesday, September 6th. StockNews.com began coverage on shares of HealthEquity in a research report on Thursday, October 5th. They issued a “hold” rating on the stock. Deutsche Bank Aktiengesellschaft boosted their price target on shares of HealthEquity from $71.00 to $72.00 and gave the company a “buy” rating in a research report on Thursday, September 7th. Barrington Research boosted their price target on shares of HealthEquity from $80.00 to $85.00 and gave the company an “outperform” rating in a research report on Wednesday, September 6th. Finally, Robert W. Baird raised shares of HealthEquity from a “neutral” rating to an “outperform” rating and boosted their price objective for the company from $79.00 to $87.00 in a research note on Thursday, September 21st. One research analyst has rated the stock with a hold rating and seven have assigned a buy rating to the company’s stock. According to data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus target price of $84.14.

HealthEquity Trading Down 3.5 %

The company has a debt-to-equity ratio of 0.45, a quick ratio of 4.09 and a current ratio of 4.09. The firm has a market cap of $5.49 billion, a PE ratio of 427.60, a PEG ratio of 1.88 and a beta of 0.77. The stock’s 50 day simple moving average is $71.38 and its 200 day simple moving average is $64.91.

HealthEquity (NASDAQ:HQY) last released its quarterly earnings results on Tuesday, September 5th. The company reported $0.34 EPS for the quarter, topping analysts’ consensus estimates of $0.28 by $0.06. HealthEquity had a net margin of 1.37% and a return on equity of 5.08%. The business had revenue of $243.55 million during the quarter, compared to analysts’ expectations of $238.89 million. On average, sell-side analysts forecast that HealthEquity, Inc. will post 1.35 earnings per share for the current fiscal year.

Insiders Place Their Bets

In other HealthEquity news, insider Tyson D. Murdock sold 1,000 shares of the business’s stock in a transaction that occurred on Friday, October 13th. The shares were sold at an average price of $76.55, for a total value of $76,550.00. Following the completion of the transaction, the insider now owns 68,818 shares of the company’s stock, valued at approximately $5,268,017.90. The transaction was disclosed in a filing with the SEC, which is available through this link. In other news, insider Tyson D. Murdock sold 1,000 shares of the company’s stock in a transaction on Friday, October 13th. The shares were sold at an average price of $76.55, for a total value of $76,550.00. Following the completion of the sale, the insider now owns 68,818 shares of the company’s stock, valued at approximately $5,268,017.90. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Also, CEO Jon Kessler sold 46,818 shares of the company’s stock in a transaction on Wednesday, September 27th. The shares were sold at an average price of $75.03, for a total transaction of $3,512,754.54. Following the completion of the sale, the chief executive officer now directly owns 213,991 shares of the company’s stock, valued at approximately $16,055,744.73. The disclosure for this sale can be found here. Insiders sold a total of 62,144 shares of company stock valued at $4,622,991 in the last quarter. Corporate insiders own 2.70% of the company’s stock.

Institutional Investors Weigh In On HealthEquity

A number of institutional investors have recently made changes to their positions in the business. Amica Mutual Insurance Co. purchased a new stake in shares of HealthEquity in the 3rd quarter valued at $2,086,000. Amica Retiree Medical Trust bought a new stake in HealthEquity during the 3rd quarter valued at $261,000. Lmcg Investments LLC bought a new stake in HealthEquity during the 3rd quarter valued at $865,000. Lisanti Capital Growth LLC bought a new stake in HealthEquity during the 3rd quarter valued at $13,221,000. Finally, Principal Financial Group Inc. raised its holdings in HealthEquity by 0.4% during the 3rd quarter. Principal Financial Group Inc. now owns 340,740 shares of the company’s stock valued at $24,891,000 after buying an additional 1,434 shares during the last quarter. Hedge funds and other institutional investors own 98.46% of the company’s stock.

About HealthEquity

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, compare treatment options and prices, receive personalized benefit and clinical information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.